AMCP Launches Online Biosimilars Resource Center for Pharmacists, Physicians, Other Providers

PRESS RELEASEAlexandria, Va., June 28, 2016

— The Academy of Managed Care Pharmacy is proud to announce the launch of the Biosimilars Resource Center (BRC), an unbiased, policy-neutral repository of educational resources and information on biosimilars for pharmacists, physicians, nurses and other health care providers.

The site was developed in partnership with leading national pharmacy organizations and can be accessed at

www.biosimilarsresourcecenter

.org

.

“Biosimilars are new to the U.S. market, and many health care professionals are still unfamiliar with their potential to improve patient care and lower costs,” says AMCP CEO Susan A. Cantrell, RPh, CAE. “We understand that providers will have many questions about biosimilars, so we are committed to making BRC a comprehensive, one-stop resource for unbiased, up-to-date information on these products.”

The BRC website will provide a comprehensive range of educational and resource materials aimed at pharmacists, physicians and other providers, including frequently asked questions, whitepapers, web-based educational seminars, continuing education programs and journal articles. The site will be continually updated as the latest information, laws and regulations become available.

Biosimilars are less expensive versions of originator biological therapies that have made remarkable progress in treating debilitating diseases such as cancer and rheumatoid arthritis. Biosimilars have been available in Europe for more than 10 years and only recently introduced in the U.S. market.

“Our initiative to educate U.S. health care providers about the benefits of biosimilars will be critical in ensuring that the therapies become widely adopted and utilized in a safe and effective manner,” Cantrell says. “AMCP is proud to take the lead in this effort.”

The BRC does not accept advertising or corporate sponsorship, and will maintain complete neutrality in the information it presents.